- Home
- Publications
- Publication Search
- Publication Details
Title
Therapeutic Effects of an Anti-Myc Drug on Mouse Pancreatic Cancer
Authors
Keywords
-
Journal
JNCI-Journal of the National Cancer Institute
Volume 106, Issue 12, Pages -
Publisher
Oxford University Press (OUP)
Online
2014-10-12
DOI
10.1093/jnci/dju320
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Dormant Cancer Cells Contribute to Residual Disease in a Model of Reversible Pancreatic Cancer
- (2013) W.-c. Lin et al. CANCER RESEARCH
- The rise and fall of cancer mortality in the USA: why does pancreatic cancer not follow the trend?
- (2013) Jiemin Ma et al. Future Oncology
- Genetically engineered mouse models of pancreatic adenocarcinoma
- (2013) Carmen Guerra et al. Molecular Oncology
- Advanced-stage pancreatic cancer: therapy options
- (2013) Jens Werner et al. Nature Reviews Clinical Oncology
- Pathogenesis of Pancreatic Cancer
- (2013) L. Charles Murtaugh TOXICOLOGIC PATHOLOGY
- Oxidants, antioxidants and the current incurability of metastatic cancers
- (2013) J. Watson Open Biology
- KrasG12D-Induced IKK2/β/NF-κB Activation by IL-1α and p62 Feedforward Loops Is Required for Development of Pancreatic Ductal Adenocarcinoma
- (2012) Jianhua Ling et al. CANCER CELL
- Genetically Engineered Mouse Models of Pancreatic Cancer
- (2012) Christoph Benedikt Westphalen et al. CANCER JOURNAL
- Integrative Survival-Based Molecular Profiling of Human Pancreatic Cancer
- (2012) Timothy R. Donahue et al. CLINICAL CANCER RESEARCH
- What We Have Learned About Pancreatic Cancer From Mouse Models
- (2012) Pedro A. Pérez–Mancera et al. GASTROENTEROLOGY
- Pancreatic cancer genomes reveal aberrations in axon guidance pathway genes
- (2012) Andrew V. Biankin et al. NATURE
- The Action Mechanism of the Myc Inhibitor Termed Omomyc May Give Clues on How to Target Myc for Cancer Therapy
- (2011) Mauro Savino et al. PLoS One
- The Quassinoid Derivative NBT-272 Targets Both the AKT and ERK Signaling Pathways in Embryonal Tumors
- (2010) D. Castelletti et al. MOLECULAR CANCER THERAPEUTICS
- Notch2 is required for progression of pancreatic intraepithelial neoplasia and development of pancreatic ductal adenocarcinoma
- (2010) P. K. Mazur et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Ras Activity Levels Control the Development of Pancreatic Diseases
- (2009) Baoan Ji et al. GASTROENTEROLOGY
- Igf1r as a therapeutic target in a mouse model of basal-like breast cancer
- (2009) A. Klinakis et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Efficacy, pharmacokinetics, tisssue distribution, and metabolism of the Myc–Max disruptor, 10058-F4 [Z,E]-5-[4-ethylbenzylidine]-2-thioxothiazolidin-4-one, in mice
- (2008) Jianxia Guo et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Pancreatic Inactivation of c-Myc Decreases Acinar Mass and Transdifferentiates Acinar Cells Into Adipocytes in Mice
- (2008) Claire Bonal et al. GASTROENTEROLOGY
- In vivoevaluation andin vitrometabolism of leuprolide in mice-mass spectrometry-based biomarker measurement for efficacy and toxicity
- (2008) Zacharias D. Sofianos et al. JOURNAL OF MASS SPECTROMETRY
- Modelling Myc inhibition as a cancer therapy
- (2008) Laura Soucek et al. NATURE
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started